Zobrazeno 1 - 10
of 7 545
pro vyhledávání: '"NK cell lectin-like receptor subfamily"'
Autor:
Ngiow SF; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Manne S; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Huang YJ; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Azar T; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA., Chen Z; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Mathew D; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Chen Q; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Khan O; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Wu JE; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Alcalde V; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA., Flowers AJ; Tara Miller Melanoma Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., McClain S; Tara Miller Melanoma Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Baxter AE; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Kurachi M; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Shi J; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Huang AC; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA., Giles JR; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Sharpe AH; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA; Gene Lay Institute of Immunology and Inflammation at Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Vignali DAA; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA; Cancer Immunology and Immunotherapy Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Wherry EJ; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: wherry@pennmedicine.upenn.edu.
Publikováno v:
Cell [Cell] 2024 Aug 08; Vol. 187 (16), pp. 4336-4354.e19.
Autor:
Ljubič M; National Institute of Chemistry, Hajdrihova 19, 1000 Ljubljana, Slovenia.; Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, 1000 Ljubljana, Slovenia., Perdih A; National Institute of Chemistry, Hajdrihova 19, 1000 Ljubljana, Slovenia.; Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, 1000 Ljubljana, Slovenia., Borišek J; National Institute of Chemistry, Hajdrihova 19, 1000 Ljubljana, Slovenia.
Publikováno v:
Journal of chemical information and modeling [J Chem Inf Model] 2024 Dec 23; Vol. 64 (24), pp. 9374-9387. Date of Electronic Publication: 2024 Dec 02.
Autor:
Desimio MG; Research Unit of Primary Immunodeficiency, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Covino DA; Research Unit of Primary Immunodeficiency, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Cancrini C; Research Unit of Primary Immunodeficiency, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.; Department of Systems Medicine, University of Rome 'Tor Vergata', Rome, Italy., Doria M; Research Unit of Primary Immunodeficiency, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Nov 29; Vol. 15, pp. 1467304. Date of Electronic Publication: 2024 Nov 29 (Print Publication: 2024).
Autor:
Tsao HW; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Anderson S; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Finn KJ; Calico Life Sciences, South San Francisco, CA, USA., Perera JJ; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Pass LF; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Schneider EM; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Jiang A; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Fetterman R; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Chuong CL; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Kozuma K; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Stickler MM; Calico Life Sciences, South San Francisco, CA, USA., Creixell M; Calico Life Sciences, South San Francisco, CA, USA., Klaeger S; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA., Phulphagar KM; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA., Rachimi S; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA., Verzani EK; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA., Olsson N; Calico Life Sciences, South San Francisco, CA, USA., Dubrot J; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Pech MF; Calico Life Sciences, South San Francisco, CA, USA., Silkworth W; Calico Life Sciences, South San Francisco, CA, USA., Lane-Reticker SK; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Allen PM; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Ibrahim K; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Knudsen NH; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Cheng AY; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Long AH; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Ebrahimi-Nik H; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Kim SY; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Du PP; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Iracheta-Vellve A; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Robitschek EJ; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Suermondt JSMT; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Davis TGR; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Wolfe CH; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Atluri T; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Olander KE; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Rush JS; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA., Sundberg TB; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA., McAllister FE; Calico Life Sciences, South San Francisco, CA, USA., Abelin JG; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA., Firestone A; Calico Life Sciences, South San Francisco, CA, USA., Stokoe D; Calico Life Sciences, South San Francisco, CA, USA., Carr SA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA., Harding FA; Calico Life Sciences, South San Francisco, CA, USA. Electronic address: fah@calicolabs.com., Yates KB; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA. Electronic address: yates@broadinstitute.org., Manguso RT; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA. Electronic address: rmanguso@broadinstitute.org.
Publikováno v:
Immunity [Immunity] 2024 Dec 10; Vol. 57 (12), pp. 2863-2878.e12. Date of Electronic Publication: 2024 Nov 18.
Autor:
Hasan MZ; Primate Genetics Laboratory, German Primate Center, Leibniz-Institute for Primate Research, Göttingen, Germany.; PhD Program Molecular Biology of Cells, GGNB, Georg August University, Göttingen, Germany., Claus M; Department for Immunology, Leibniz Research Centre for Working Environment and Human Factors (IfADo) at TU Dortmund, Dortmund, Germany., Krüger N; Platform Infection Models, German Primate Center, Leibniz-Institute for Primate Research, Göttingen, Germany., Reusing S; Institute for Transplantation Diagnostics and Cell Therapeutics, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany., Gall E; Institute for Transfusion Medicine, Hannover Medical School, Hannover, Germany., Bade-Döding C; Institute for Transfusion Medicine, Hannover Medical School, Hannover, Germany., Braun A; Fraunhofer Institute for Toxicology and Experimental Medicine, Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease (BREATH), Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD, Hannover, Germany.; Institute of Immunology, Medical School Hannover, Hannover, Germany., Watzl C; Department for Immunology, Leibniz Research Centre for Working Environment and Human Factors (IfADo) at TU Dortmund, Dortmund, Germany., Uhrberg M; Institute for Transplantation Diagnostics and Cell Therapeutics, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany., Walter L; Primate Genetics Laboratory, German Primate Center, Leibniz-Institute for Primate Research, Göttingen, Germany.
Publikováno v:
Emerging microbes & infections [Emerg Microbes Infect] 2024 Dec; Vol. 13 (1), pp. 2361019. Date of Electronic Publication: 2024 Jun 27.
Autor:
Li J; Key Laboratory of Immune Response and Immunotherapy, The Institute of Immunology, Biomedical Sciences and Health Laboratory of Anhui Province, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China., Wang X; Key Laboratory of Immune Response and Immunotherapy, The Institute of Immunology, Biomedical Sciences and Health Laboratory of Anhui Province, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China. Electronic address: wangxianwei@ustc.edu.cn., Cao G; Hefei TG ImmunoPharma Corporation Limited, Hefei, China., Wu Y; Hefei TG ImmunoPharma Corporation Limited, Hefei, China., Cheng M; Key Laboratory of Immune Response and Immunotherapy, The Institute of Immunology, Biomedical Sciences and Health Laboratory of Anhui Province, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China., Chen Y; Key Laboratory of Immune Response and Immunotherapy, The Institute of Immunology, Biomedical Sciences and Health Laboratory of Anhui Province, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China., Sun H; Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China., Sun R; Key Laboratory of Immune Response and Immunotherapy, The Institute of Immunology, Biomedical Sciences and Health Laboratory of Anhui Province, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China., Peng H; Key Laboratory of Immune Response and Immunotherapy, The Institute of Immunology, Biomedical Sciences and Health Laboratory of Anhui Province, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China. Electronic address: huipeng@ustc.edu.cn., Tian Z; Key Laboratory of Immune Response and Immunotherapy, The Institute of Immunology, Biomedical Sciences and Health Laboratory of Anhui Province, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China; Hefei TG ImmunoPharma Corporation Limited, Hefei, China. Electronic address: tzg@ustc.edu.cn.
Publikováno v:
Cancer letters [Cancer Lett] 2024 Nov 28; Vol. 605, pp. 217305. Date of Electronic Publication: 2024 Oct 17.
Autor:
Jin C; Department of Otolaryngology, The Second Hospital of Jilin University, No.4026, Yatai street, Nanguan District, Changchun, 130000, China., Li X; Department of Radiology, The Second Hospital of Jilin University, Changchun, 130000, China., Zhang C; Department of Tumor Hematology, The Second Hospital of Jilin University, No.4026, Yatai street, Nanguan District, Changchun, 130000, China. zhangchaohe@jlu.edu.cn.
Publikováno v:
Molecular medicine (Cambridge, Mass.) [Mol Med] 2024 Nov 23; Vol. 30 (1), pp. 230. Date of Electronic Publication: 2024 Nov 23.
Autor:
Obajdin J; King's College London, School of Cancer and Pharmaceutical Sciences, CAR Mechanics Lab, London SE1 9RT, UK., Larcombe-Young D; King's College London, School of Cancer and Pharmaceutical Sciences, CAR Mechanics Lab, London SE1 9RT, UK., Glover M; Leucid Bio Ltd, Guy's Hospital, London SE1 9RT, UK., Kausar F; Leucid Bio Ltd, Guy's Hospital, London SE1 9RT, UK., Hull CM; Leucid Bio Ltd, Guy's Hospital, London SE1 9RT, UK., Flaherty KR; King's College London, Department of Infectious Diseases, School of Immunology and Microbial Sciences, Guy's Hospital, London SE1 9RT, UK., Tan G; King's College London, School of Cancer and Pharmaceutical Sciences, CAR Mechanics Lab, London SE1 9RT, UK., Beatson RE; Department of Respiratory Medicine, Division of Medicinal Sciences, University College London, London, UK., Dunbar P; Leucid Bio Ltd, Guy's Hospital, London SE1 9RT, UK., Mazza R; Leucid Bio Ltd, Guy's Hospital, London SE1 9RT, UK., Bove C; Leucid Bio Ltd, Guy's Hospital, London SE1 9RT, UK., Taylor C; Leucid Bio Ltd, Guy's Hospital, London SE1 9RT, UK., Bille A; Department of Thoracic Surgery, Guy's and St. Thomas' NHS Trust Foundation, London SE1 9RT, UK., Spillane KM; Department of Physics, King's College London, London WC2R 2LS, UK., Cozzetto D; Division of Digestive Diseases, Faculty of Medicine, Imperial College London, London W12 0NN, UK., Vigilante A; King's College London, Centre for Stem Cells and Regenerative Medicine & Institute for Liver Studies, Guy's Hospital, London SE1 9RT, UK., Schurich A; King's College London, Department of Infectious Diseases, School of Immunology and Microbial Sciences, Guy's Hospital, London SE1 9RT, UK., Davies DM; Leucid Bio Ltd, Guy's Hospital, London SE1 9RT, UK., Maher J; King's College London, School of Cancer and Pharmaceutical Sciences, CAR Mechanics Lab, London SE1 9RT, UK; Leucid Bio Ltd, Guy's Hospital, London SE1 9RT, UK; Department of Immunology, Eastbourne Hospital, Kings Drive, Eastbourne, East Sussex BN21 2UD, UK. Electronic address: john.maher@kcl.ac.uk.
Publikováno v:
Cell reports. Medicine [Cell Rep Med] 2024 Nov 19; Vol. 5 (11), pp. 101827.
Autor:
Fesneau O; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA., Samson KA; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA., Rosales W; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA., Jones B; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA., Moudgil T; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA., Fox BA; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA., Rajamanickam V; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA., Duhen T; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA. thomas.duhen@providence.org.
Publikováno v:
Nature communications [Nat Commun] 2024 Nov 18; Vol. 15 (1), pp. 9988. Date of Electronic Publication: 2024 Nov 18.
Autor:
Asenjo J; Immunogenetics & Histocompatibility Lab, Instituto de Investigación Sanitaria Puerta de Hierro - Segovia de Arana, Majadahonda, Spain., Moraru M; Immunogenetics & Histocompatibility Lab, Instituto de Investigación Sanitaria Puerta de Hierro - Segovia de Arana, Majadahonda, Spain., Al-Akioui-Sanz K; Immunogenetics & Histocompatibility Lab, Instituto de Investigación Sanitaria Puerta de Hierro - Segovia de Arana, Majadahonda, Spain., Altadill M; University Pompeu Fabra, Barcelona, Spain., Muntasell A; Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.; Department of Cell Biology, Physiology and Immunology, Universitat Autonòma de Barcelona, Bellaterra, Spain., López-Botet M; University Pompeu Fabra, Barcelona, Spain.; Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Vilches C; Immunogenetics & Histocompatibility Lab, Instituto de Investigación Sanitaria Puerta de Hierro - Segovia de Arana, Majadahonda, Spain.; Organización Nacional de Trasplantes, Ministerio de Sanidad, Madrid, Spain.
Publikováno v:
HLA [HLA] 2024 Nov; Vol. 104 (5), pp. e15764.